Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 1/2 5Phase 2 2Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Multiple Myeloma 19Solid Tumor 18Breast Neoplasms 14Sarcoma 13Head and Neck Neoplasms 13Colorectal Neoplasms 13Neoplasms 12Lymphoma, B-Cell 12Squamous Cell Carcinoma of Head and Neck 11Pancreatic Neoplasms 11Leukemia, Myeloid, Acute 11Stomach Neoplasms 10Melanoma 10Lymphoma 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Prostatic Neoplasms 7Leukemia 7Burkitt Lymphoma 7Advanced Solid Tumors 7Ovarian Neoplasms 6Hematologic Neoplasms 6Glioblastoma 6Recurrence 5Osteosarcoma 5Lymphoma, Non-Hodgkin 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Neoplasm Metastasis 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × INDUSTRY × Turcot syndrome × Clear all
NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Radiopharm Theranostics, Ltd

Phase EARLY_PHASE1 Recruiting
30 enrolled
BreastDermatologicGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡